Product Suitability Screening
Overview
Evaluate investment products against individual client profiles to determine suitability and document the best interest rationale. This skill screens products across risk, cost, complexity, liquidity, tax efficiency, and objective alignment dimensions, compares alternatives, and produces Reg BI-compliant recommendation documentation. Outputs ensure every product recommendation has a defensible suitability basis and that lower-cost, less-complex alternatives were considered.
When to Use
- Evaluating a specific product for recommendation to a client
- Comparing multiple product alternatives for the same investment objective
- Conducting annual product shelf reviews for the advisory platform
- Assessing complex or alternative products for client appropriateness
- Documenting Reg BI best interest determination for a recommendation
- Responding to compliance inquiries about product selection rationale
Required Inputs
| Input |
Description |
Format |
| Product details |
Prospectus, fact sheet, fee schedule, risk characteristics |
Product documentation |
| Client profile |
Risk tolerance, time horizon, net worth, income, goals, sophistication |
Client data |
| Alternative products |
Comparable products available on the platform |
Product shelf data |
| Account type |
Registration, tax status, purpose designation |
Account records |
| Existing holdings |
Current portfolio composition and overlap analysis |
Custodian data |
| Compliance rules |
Firm-approved product list, concentration limits, suitability criteria |
Compliance policy |
Methodology
Step 1 — Product Characteristic Assessment
Catalog the product's key characteristics for suitability evaluation:
Risk characteristics:
- Asset class and sub-strategy classification
- Historical volatility (standard deviation, 3/5/10 year)
- Maximum drawdown (worst peak-to-trough decline)
- Beta relative to broad market index
- Credit risk (if fixed income: average credit quality, default rate)
- Concentration risk (top holdings, sector concentration)
- Leverage usage (if any)
- Derivative usage and counterparty risk
Cost structure:
- Management fee / expense ratio
- Sales charges (front-end load, deferred sales charge, level load)
- 12b-1 fees
- Performance fees (if applicable)
- Surrender charges and schedule
- Trading costs (bid-ask spreads for ETFs, transaction fees for mutual funds)
- Total cost of ownership (TCO) over 1, 3, 5, 10-year horizons
Liquidity characteristics:
- Daily liquidity (open-end mutual fund, ETF)
- Periodic liquidity (interval fund — quarterly/semi-annual tender)
- Lock-up period (private fund — 1–10+ years)
- Redemption gates and suspension provisions
- Secondary market availability and typical discount/premium
Complexity assessment:
| Level |
Examples |
Appropriate For |
| 1 — Basic |
Index funds, bond funds, balanced funds |
All clients |
| 2 — Moderate |
Active equity, sector funds, REITs, high-yield |
Intermediate+ clients |
| 3 — Complex |
Options strategies, alternatives, structured notes |
Sophisticated clients with specific need |
| 4 — Highly complex |
Private equity, hedge funds, derivatives-based |
Qualified/accredited investors with advisor guidance |
Tax characteristics:
- Tax efficiency rating (turnover rate, distribution history)
- Capital gains distribution frequency and magnitude
- Qualified dividend percentage
- Tax-loss harvesting compatibility
- Appropriate account type (taxable, tax-deferred, tax-exempt)
Step 2 — Client Profile Matching
Score the product against the client's profile across each dimension:
| Dimension |
Client Requirement |
Product Characteristic |
Match |
| Risk level |
[Score/Category] |
[Score/Category] |
[✓/✗/~] |
| Time horizon |
[X years] |
[Min recommended hold: X years] |
[✓/✗/~] |
| Liquidity need |
[Within X days] |
[Liquidity: X] |
[✓/✗/~] |
| Income need |
[$X annual] |
[Yield: X%] |
[✓/✗/~] |
| Sophistication |
[Level] |
[Complexity: Level X] |
[✓/✗/~] |
| Tax situation |
[Rate: XX%] |
[Tax efficiency: X] |
[✓/✗/~] |
| Net worth / QI |
[$X] |
[Min: $X / Accredited req] |
[✓/✗/~] |
| Concentration |
[Current: X%] |
[Post-add: X%] |
[✓/✗/~] |
Automatic disqualifiers:
- Product risk exceeds client's governing risk level
- Client cannot meet minimum investment or accreditation requirements
- Liquidity terms exceed client's liquidity needs
- Product complexity exceeds client's demonstrated sophistication
- Position would breach concentration limits
Step 3 — Alternative Product Comparison
Identify and compare alternatives that could serve the same investment objective:
| Criterion |
Product A (Proposed) |
Product B (Alt 1) |
Product C (Alt 2) |
| Strategy |
[Description] |
[Description] |
[Description] |
| Expense ratio |
X.XX% |
X.XX% |
X.XX% |
| 5Y return (ann.) |
X.XX% |
X.XX% |
X.XX% |
| Sharpe ratio (5Y) |
X.XX |
X.XX |
X.XX |
| Max drawdown |
-XX% |
-XX% |
-XX% |
| Liquidity |
[Daily/Qtly/Lock-up] |
[Daily/Qtly/Lock-up] |
[Daily/Qtly/Lock-up] |
| Min investment |
$X |
$X |
$X |
| Tax efficiency |
[High/Med/Low] |
[High/Med/Low] |
[High/Med/Low] |
Cost comparison over client's time horizon:
- 10-year cost of ownership per $100,000 invested:
- Product A: $[X]
- Product B: $[X]
- Product C: $[X]
Reg BI requirement: If recommending a higher-cost product, document the specific, articulable reason why it is in the client's best interest despite the cost differential (e.g., access to strategy unavailable at lower cost, superior risk-adjusted returns, tax advantages, specific client need).
Step 4 — Conflict of Interest Assessment
Identify and document all material conflicts:
- Revenue sharing: Does the product provider pay the firm revenue sharing or shelf-space fees?
- Proprietary product: Is this a firm-affiliated product? If yes, document why it's preferred over third-party alternatives
- Compensation differential: Does the advisor receive higher compensation for this product vs. alternatives?
- 12b-1 fees: Are there ongoing distribution fees that benefit the firm?
- Non-cash compensation: Any conferences, trips, or gifts from the product provider?
For each identified conflict, document the mitigation:
- Disclosure to client (written, verbal, Form CRS reference)
- Offsetting client benefit that justifies the recommendation despite the conflict
- Compliance-approved rationale
Step 5 — Portfolio Fit Analysis
Assess how the product fits within the client's existing portfolio:
- Asset class gap: Does this product fill an allocation gap vs. the IPS target?
- Overlap analysis: Correlation with existing holdings — avoid adding redundant exposure
- Diversification impact: How does adding this product change portfolio risk metrics?
- Portfolio volatility before and after addition
- Maximum drawdown before and after
- Sharpe ratio before and after
- Rebalancing implications: Will adding this product require selling other positions?
- Portfolio-level cost impact: How does this product change the overall portfolio expense ratio?
Step 6 — Best Interest Determination Documentation
Compile the Reg BI best interest determination:
Care obligation documentation:
- Reasonable basis: Product is suitable for at least some investors (general suitability)
- Customer-specific: Product is suitable for THIS client based on their profile
- Quantitative: Recommendation frequency is reasonable (no excessive trading)
- Alternatives considered: At least 2 alternatives evaluated with documented rationale for selection
Documentation template:
Best Interest Determination — [Client Name] — [Date]
Product recommended: [Name]
Investment objective served: [Objective]
Suitability basis:
- Client risk profile: [Category] — Product risk: [Category] — Match: [Yes]
- Time horizon: [Client X years] — Product minimum: [X years] — Match: [Yes]
- Liquidity: [Client need] — Product liquidity: [Terms] — Match: [Yes]
Alternatives considered:
- [Alt 1]: Not selected because [specific reason]
- [Alt 2]: Not selected because [specific reason]
Cost analysis: [Proposed product cost vs. alternatives — justification if higher cost]
Conflicts: [Identified conflicts and mitigations]
Conclusion: This recommendation is in [Client Name]'s best interest because
[specific, articulable reasons tied to the client's individual circumstances].
Step 7 — Ongoing Monitoring Framework
Establish post-recommendation monitoring:
- Performance monitoring: Review product performance vs. expectations quarterly
- Suitability reassessment: Re-evaluate product suitability at each periodic review
- Cost competitiveness: Reassess cost vs. alternatives annually (fee reductions, new entrants)
- Product changes: Monitor for material changes (manager departure, strategy drift, fee increases)
- Client changes: Reassess suitability when client circumstances change materially
Output Specification
## Product Suitability Screening Report
### Product Overview
- Name: [Product name]
- Category: [Asset class / strategy]
- Expense ratio: [X.XX%]
- Risk level: [Score/Category]
- Complexity: Level [1–4]
- Liquidity: [Terms]
### Client Suitability Match
| Dimension | Requirement | Product | Result |
|-----------|------------|---------|--------|
| [Dim] | [Req] | [Product char] | [Pass/Fail/Marginal] |
### Alternative Comparison
[Comparison table with rationale for selection]
### Conflict Assessment
[Conflicts identified and mitigations documented]
### Portfolio Fit
- Allocation gap filled: [Yes/No — which asset class]
- Diversification impact: [Positive/Neutral/Negative]
- Portfolio cost impact: [+/- X bps]
### Best Interest Determination
[Completed Reg BI documentation template]
### Recommendation: [Suitable / Not Suitable / Suitable with Conditions]
Analysis Framework
Apply the PRISM framework:
- Product analysis — Catalog risk, cost, liquidity, complexity, and tax characteristics
- Requirements matching — Score product against client profile dimensions
- Interest conflicts — Identify and document all material conflicts with mitigations
- Selection rationale — Compare alternatives and document why this product was chosen
- Monitoring — Establish ongoing suitability surveillance framework
Examples
Example 1 — Index Fund vs. Active Fund Comparison
Client: 45-year-old moderate-risk investor, $500K taxable account, 20-year horizon. Objective: US large-cap equity exposure. Product A: Vanguard S&P 500 ETF (VOO), ER 0.03%. Product B: Active large-cap fund, ER 0.75%. 10-year cost per $100K: VOO $300 vs. Active $7,500. Active fund has underperformed benchmark 7 of 10 years. No specific alpha thesis that justifies 25x cost differential. Recommendation: VOO — lower cost, better tax efficiency, consistent benchmark exposure. Best interest basis: cost advantage of $72,000 over 10 years per $1M invested, with no demonstrated value-add from active management for this client's objectives.
Example 2 — Alternative Investment Screening
Client: 62-year-old, $3.2M portfolio, moderate-conservative risk, needs $10K/month income starting in 2 years. Product: Private real estate fund, 5-year lock-up, 7% target yield, minimum $250K. Screening result: NOT SUITABLE. Reason: Client's 2-year income need conflicts with 5-year lock-up. At $250K investment, 7.8% of portfolio would be illiquid — acceptable, but the income timing mismatch is the critical issue. Alternative: Publicly traded REIT fund with daily liquidity, 4.2% yield, no lock-up. Lower yield but aligned with client's liquidity and income timing requirements.
Guidelines
- Screen every product recommendation against at least 2 alternatives
- Document cost comparisons over the client's specific time horizon, not generic periods
- Never recommend a higher-cost product without an articulable, client-specific benefit
- Treat complexity as a risk factor — don't recommend Level 3–4 products without specific need
- Verify accreditation and minimum investment requirements BEFORE discussing with client
- Update product suitability assessments when either the product or the client changes materially
- Maintain the best interest determination file for each recommendation per SEC record retention rules
- Coordinate with compliance on any products flagged for heightened supervision
Validation Checklist
1---2name: product-suitability-screening3description: Screen investment products for suitability alignment with specific client profiles per Reg BI and fiduciary standards. Use when evaluating new product recommendations, comparing alternative products for a client, conducting product shelf reviews, assessing complex products for appropriateness, or documenting the best interest determination for regulatory compliance.45metadata:6 display_name: "Product Suitability Screening"7 short_description: "Screen investment product suitability per Reg BI standards"8 default_prompt: "Check my product suitability screening for gaps risks and required fixes"9 version: "1.0.0"10 tags:11 - financial-services12 icon_path: "assets/icon.png"13---1415# Product Suitability Screening1617## Overview1819Evaluate investment products against individual client profiles to determine suitability and document the best interest rationale. This skill screens products across risk, cost, complexity, liquidity, tax efficiency, and objective alignment dimensions, compares alternatives, and produces Reg BI-compliant recommendation documentation. Outputs ensure every product recommendation has a defensible suitability basis and that lower-cost, less-complex alternatives were considered.2021## When to Use2223- Evaluating a specific product for recommendation to a client24- Comparing multiple product alternatives for the same investment objective25- Conducting annual product shelf reviews for the advisory platform26- Assessing complex or alternative products for client appropriateness27- Documenting Reg BI best interest determination for a recommendation28- Responding to compliance inquiries about product selection rationale2930## Required Inputs3132| Input | Description | Format |33|-------|-------------|--------|34| Product details | Prospectus, fact sheet, fee schedule, risk characteristics | Product documentation |35| Client profile | Risk tolerance, time horizon, net worth, income, goals, sophistication | Client data |36| Alternative products | Comparable products available on the platform | Product shelf data |37| Account type | Registration, tax status, purpose designation | Account records |38| Existing holdings | Current portfolio composition and overlap analysis | Custodian data |39| Compliance rules | Firm-approved product list, concentration limits, suitability criteria | Compliance policy |4041## Methodology4243### Step 1 — Product Characteristic Assessment4445Catalog the product's key characteristics for suitability evaluation:4647**Risk characteristics:**48- Asset class and sub-strategy classification49- Historical volatility (standard deviation, 3/5/10 year)50- Maximum drawdown (worst peak-to-trough decline)51- Beta relative to broad market index52- Credit risk (if fixed income: average credit quality, default rate)53- Concentration risk (top holdings, sector concentration)54- Leverage usage (if any)55- Derivative usage and counterparty risk5657**Cost structure:**58- Management fee / expense ratio59- Sales charges (front-end load, deferred sales charge, level load)60- 12b-1 fees61- Performance fees (if applicable)62- Surrender charges and schedule63- Trading costs (bid-ask spreads for ETFs, transaction fees for mutual funds)64- Total cost of ownership (TCO) over 1, 3, 5, 10-year horizons6566**Liquidity characteristics:**67- Daily liquidity (open-end mutual fund, ETF)68- Periodic liquidity (interval fund — quarterly/semi-annual tender)69- Lock-up period (private fund — 1–10+ years)70- Redemption gates and suspension provisions71- Secondary market availability and typical discount/premium7273**Complexity assessment:**74| Level | Examples | Appropriate For |75|-------|---------|----------------|76| 1 — Basic | Index funds, bond funds, balanced funds | All clients |77| 2 — Moderate | Active equity, sector funds, REITs, high-yield | Intermediate+ clients |78| 3 — Complex | Options strategies, alternatives, structured notes | Sophisticated clients with specific need |79| 4 — Highly complex | Private equity, hedge funds, derivatives-based | Qualified/accredited investors with advisor guidance |8081**Tax characteristics:**82- Tax efficiency rating (turnover rate, distribution history)83- Capital gains distribution frequency and magnitude84- Qualified dividend percentage85- Tax-loss harvesting compatibility86- Appropriate account type (taxable, tax-deferred, tax-exempt)8788### Step 2 — Client Profile Matching8990Score the product against the client's profile across each dimension:9192| Dimension | Client Requirement | Product Characteristic | Match |93|-----------|-------------------|----------------------|-------|94| Risk level | [Score/Category] | [Score/Category] | [✓/✗/~] |95| Time horizon | [X years] | [Min recommended hold: X years] | [✓/✗/~] |96| Liquidity need | [Within X days] | [Liquidity: X] | [✓/✗/~] |97| Income need | [$X annual] | [Yield: X%] | [✓/✗/~] |98| Sophistication | [Level] | [Complexity: Level X] | [✓/✗/~] |99| Tax situation | [Rate: XX%] | [Tax efficiency: X] | [✓/✗/~] |100| Net worth / QI | [$X] | [Min: $X / Accredited req] | [✓/✗/~] |101| Concentration | [Current: X%] | [Post-add: X%] | [✓/✗/~] |102103**Automatic disqualifiers:**104- Product risk exceeds client's governing risk level105- Client cannot meet minimum investment or accreditation requirements106- Liquidity terms exceed client's liquidity needs107- Product complexity exceeds client's demonstrated sophistication108- Position would breach concentration limits109110### Step 3 — Alternative Product Comparison111112Identify and compare alternatives that could serve the same investment objective:113114| Criterion | Product A (Proposed) | Product B (Alt 1) | Product C (Alt 2) |115|-----------|---------------------|-------------------|-------------------|116| Strategy | [Description] | [Description] | [Description] |117| Expense ratio | X.XX% | X.XX% | X.XX% |118| 5Y return (ann.) | X.XX% | X.XX% | X.XX% |119| Sharpe ratio (5Y) | X.XX | X.XX | X.XX |120| Max drawdown | -XX% | -XX% | -XX% |121| Liquidity | [Daily/Qtly/Lock-up] | [Daily/Qtly/Lock-up] | [Daily/Qtly/Lock-up] |122| Min investment | $X | $X | $X |123| Tax efficiency | [High/Med/Low] | [High/Med/Low] | [High/Med/Low] |124125**Cost comparison over client's time horizon:**126- 10-year cost of ownership per $100,000 invested:127 - Product A: $[X]128 - Product B: $[X]129 - Product C: $[X]130131**Reg BI requirement**: If recommending a higher-cost product, document the specific, articulable reason why it is in the client's best interest despite the cost differential (e.g., access to strategy unavailable at lower cost, superior risk-adjusted returns, tax advantages, specific client need).132133### Step 4 — Conflict of Interest Assessment134135Identify and document all material conflicts:136137- **Revenue sharing**: Does the product provider pay the firm revenue sharing or shelf-space fees?138- **Proprietary product**: Is this a firm-affiliated product? If yes, document why it's preferred over third-party alternatives139- **Compensation differential**: Does the advisor receive higher compensation for this product vs. alternatives?140- **12b-1 fees**: Are there ongoing distribution fees that benefit the firm?141- **Non-cash compensation**: Any conferences, trips, or gifts from the product provider?142143For each identified conflict, document the mitigation:144- Disclosure to client (written, verbal, Form CRS reference)145- Offsetting client benefit that justifies the recommendation despite the conflict146- Compliance-approved rationale147148### Step 5 — Portfolio Fit Analysis149150Assess how the product fits within the client's existing portfolio:151152- **Asset class gap**: Does this product fill an allocation gap vs. the IPS target?153- **Overlap analysis**: Correlation with existing holdings — avoid adding redundant exposure154- **Diversification impact**: How does adding this product change portfolio risk metrics?155 - Portfolio volatility before and after addition156 - Maximum drawdown before and after157 - Sharpe ratio before and after158- **Rebalancing implications**: Will adding this product require selling other positions?159- **Portfolio-level cost impact**: How does this product change the overall portfolio expense ratio?160161### Step 6 — Best Interest Determination Documentation162163Compile the Reg BI best interest determination:164165**Care obligation documentation:**166- Reasonable basis: Product is suitable for at least some investors (general suitability)167- Customer-specific: Product is suitable for THIS client based on their profile168- Quantitative: Recommendation frequency is reasonable (no excessive trading)169- Alternatives considered: At least 2 alternatives evaluated with documented rationale for selection170171**Documentation template:**172173```174Best Interest Determination — [Client Name] — [Date]175176Product recommended: [Name]177Investment objective served: [Objective]178179Suitability basis:180- Client risk profile: [Category] — Product risk: [Category] — Match: [Yes]181- Time horizon: [Client X years] — Product minimum: [X years] — Match: [Yes]182- Liquidity: [Client need] — Product liquidity: [Terms] — Match: [Yes]183184Alternatives considered:185- [Alt 1]: Not selected because [specific reason]186- [Alt 2]: Not selected because [specific reason]187188Cost analysis: [Proposed product cost vs. alternatives — justification if higher cost]189190Conflicts: [Identified conflicts and mitigations]191192Conclusion: This recommendation is in [Client Name]'s best interest because193[specific, articulable reasons tied to the client's individual circumstances].194```195196### Step 7 — Ongoing Monitoring Framework197198Establish post-recommendation monitoring:199200- **Performance monitoring**: Review product performance vs. expectations quarterly201- **Suitability reassessment**: Re-evaluate product suitability at each periodic review202- **Cost competitiveness**: Reassess cost vs. alternatives annually (fee reductions, new entrants)203- **Product changes**: Monitor for material changes (manager departure, strategy drift, fee increases)204- **Client changes**: Reassess suitability when client circumstances change materially205206## Output Specification207208```209## Product Suitability Screening Report210211### Product Overview212- Name: [Product name]213- Category: [Asset class / strategy]214- Expense ratio: [X.XX%]215- Risk level: [Score/Category]216- Complexity: Level [1–4]217- Liquidity: [Terms]218219### Client Suitability Match220| Dimension | Requirement | Product | Result |221|-----------|------------|---------|--------|222| [Dim] | [Req] | [Product char] | [Pass/Fail/Marginal] |223224### Alternative Comparison225[Comparison table with rationale for selection]226227### Conflict Assessment228[Conflicts identified and mitigations documented]229230### Portfolio Fit231- Allocation gap filled: [Yes/No — which asset class]232- Diversification impact: [Positive/Neutral/Negative]233- Portfolio cost impact: [+/- X bps]234235### Best Interest Determination236[Completed Reg BI documentation template]237238### Recommendation: [Suitable / Not Suitable / Suitable with Conditions]239```240241## Analysis Framework242243Apply the **PRISM** framework:244245- **P**roduct analysis — Catalog risk, cost, liquidity, complexity, and tax characteristics246- **R**equirements matching — Score product against client profile dimensions247- **I**nterest conflicts — Identify and document all material conflicts with mitigations248- **S**election rationale — Compare alternatives and document why this product was chosen249- **M**onitoring — Establish ongoing suitability surveillance framework250251## Examples252253**Example 1 — Index Fund vs. Active Fund Comparison**254255Client: 45-year-old moderate-risk investor, $500K taxable account, 20-year horizon. Objective: US large-cap equity exposure. Product A: Vanguard S&P 500 ETF (VOO), ER 0.03%. Product B: Active large-cap fund, ER 0.75%. 10-year cost per $100K: VOO $300 vs. Active $7,500. Active fund has underperformed benchmark 7 of 10 years. No specific alpha thesis that justifies 25x cost differential. Recommendation: VOO — lower cost, better tax efficiency, consistent benchmark exposure. Best interest basis: cost advantage of $72,000 over 10 years per $1M invested, with no demonstrated value-add from active management for this client's objectives.256257**Example 2 — Alternative Investment Screening**258259Client: 62-year-old, $3.2M portfolio, moderate-conservative risk, needs $10K/month income starting in 2 years. Product: Private real estate fund, 5-year lock-up, 7% target yield, minimum $250K. Screening result: NOT SUITABLE. Reason: Client's 2-year income need conflicts with 5-year lock-up. At $250K investment, 7.8% of portfolio would be illiquid — acceptable, but the income timing mismatch is the critical issue. Alternative: Publicly traded REIT fund with daily liquidity, 4.2% yield, no lock-up. Lower yield but aligned with client's liquidity and income timing requirements.260261## Guidelines262263- Screen every product recommendation against at least 2 alternatives264- Document cost comparisons over the client's specific time horizon, not generic periods265- Never recommend a higher-cost product without an articulable, client-specific benefit266- Treat complexity as a risk factor — don't recommend Level 3–4 products without specific need267- Verify accreditation and minimum investment requirements BEFORE discussing with client268- Update product suitability assessments when either the product or the client changes materially269- Maintain the best interest determination file for each recommendation per SEC record retention rules270- Coordinate with compliance on any products flagged for heightened supervision271272## Validation Checklist273274- [ ] Product risk, cost, liquidity, complexity, and tax characteristics fully cataloged275- [ ] Client profile matching completed across all required dimensions276- [ ] At least 2 alternative products compared with documented selection rationale277- [ ] All material conflicts of interest identified, disclosed, and mitigated278- [ ] Portfolio fit assessed including overlap, diversification, and cost impact279- [ ] Reg BI best interest determination completed with all four obligations addressed280- [ ] Cost comparison uses client-specific time horizon and investment amount281- [ ] Accreditation and minimum investment requirements verified282- [ ] Post-recommendation monitoring framework established283- [ ] Documentation archived per SEC/FINRA record retention requirements